⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15584 | 0.89 | — | — | |
| SCHEMBL15068452 | 0.89 | CA1 (0.46) | — | |
| Propene SCHEMBL29001622 | 0.86 | MEN1 (0.44) | — | |
| Fluoromethane SCHEMBL28770309 | 0.86 | — | — | |
| Propane SCHEMBL892321 | 0.86 | MEN1 (0.50) | — | |
| Propene SCHEMBL23361925 | 0.86 | MEN1 (0.44) | — | |
| Methoxymethane SCHEMBL5417681 | 0.86 | MEN1 (0.44) | — | |
| Chloromethane SCHEMBL15265334 | 0.86 | — | — | |
| Propene SCHEMBL314173 | 0.86 | MEN1 (0.44) | — | |
| Hydroxyamine SCHEMBL7152009 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7678782-B2 | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs | XENOPORT, INC. (US) | 2010-03-16 | — | — | US | disclosed |
| US-20070015716-A1 | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs | XENOPORT, INC. | 2007-01-18 | — | — | US | disclosed |
| US-7144877-B2 | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs | XENOPORT, INC. (US) | 2006-12-05 | — | — | US | disclosed |
| EP-1358200-A4 | BILE-ACID DERIVED COMPOUNDS FOR ENHANCING ORAL ABSORPTION AND SYSTEMIC BIOAVAILABILITY OF DRUGS | XENOPORT INC (US) | 2005-07-20 | — | — | EP | disclosed |
| EP-1358200-A2 | BILE-ACID DERIVED COMPOUNDS FOR ENHANCING ORAL ABSORPTION AND SYSTEMIC BIOAVAILABILITY OF DRUGS | Xenoport, Inc. (US) | 2003-11-05 | — | — | EP | disclosed |
| US-20020099041-A1 | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs | XENOPORT, INC. | 2002-07-25 | — | — | US | disclosed |
| WO-2002044324-A2 | BILE-ACID DERIVED COMPOUNDS FOR ENHANCING ORAL ABSORPTION AND SYSTEMIC BIOAVAILABILITY OF DRUGS | XENOPORT, INC. (US) | 2002-06-06 | — | — | WO | disclosed |